High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women

被引:0
|
作者
Wang, Jingmei [1 ]
Wu, Hongyan [1 ]
Zhang, Yan [2 ]
Zhang, Yifen [1 ]
Li, Xinxiu [3 ]
Zhao, Qingya [3 ]
Meng, Fanqing [1 ]
Huang, Qin [1 ,4 ,5 ]
Wang, Yaping [3 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Med Sch, Dept Med Genet, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China
[4] VA Boston Healthcare Syst, Dept Pathol & Lab Med, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
关键词
Ovarian cancer; fallopian tube cancer; Chinese women; serous tubal intraepithelial carcinoma; high-grade serous carcinoma; STAGING CLASSIFICATION; GYNECOLOGICAL CANCERS; SITE ASSIGNMENT; PERITONEUM; SURVIVAL; P53; ADENOCARCINOMA; ASSOCIATION; OBSTETRICS; MUTATIONS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: This study aimed to compare the clinicopathological features, incidence, and prognosis between type II ovarian carcinoma (OC) and fallopian tube carcinoma (FTC) in Chinese women and to analyze the origin of high-grade serous carcinoma (HGSC). Methods: Three hundreds and seventy-four OC cases and 45 FTC cases were retrospectively studied with histomorphology, tissue microarray, and immunohistochemistry. Results: Our data showed that the characteristics of OC and FTC in Chinese women were younger at diagnosis with worse prognosis. There was no significant difference between type II OC and FTC in the clinicopathological information and survival. Serous tubal intraepithelial carcinoma (STIC) were found in 41.7% (43/103) of ovarian high-grade serous carcinoma (HGSC) and 52.4% (22/42) cases of tubal HGSC, and 26 patients were found with only fallopian tube (FT) mucosal invasive carcinoma. Seventy-eight of 87 cases of ovarian HGSC with tubal lesions (STIC and/or FT mucosal invasive carcinoma) was in advanced stage. There was no significant difference between newly assigned FTC (ovarian HGSC with tubal lesions and FTC) and type II OC without tubal lesions in many clinicopathological parameters, expression of immunohistochemical indicators and survival, but type I OC was quite much different from the former two. Conclusions: Our data suggested that OC of type II and FTC might be originated from the same organ, and strongly supported the dualistic model of epithelial ovarian cancer. Moreover, this study provided a further clinical basis for the prophylactic salpingectomy to reduce the risk of OC.
引用
收藏
页码:8222 / 8232
页数:11
相关论文
共 50 条
  • [41] Genome-wide analysis of somatic mutations shared by co-occurring ovarian high-grade serous carcinomas and serous tubal intraepithelial carcinomas
    Song, Yan
    Ardin, Maude
    Cahais, Vincent
    Carreira, Christine
    Holmila, Reetta
    Villar, Stephanie
    Castells, Xavier
    Vallee, Maxime
    Heguy, Adriana
    Bringuier, Pierre-Paul
    Guo, Qin
    Zhang, Xun
    Zavadil, Jiri
    CANCER RESEARCH, 2015, 75
  • [42] Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss, Esther Louise
    Evans, Tim
    Pearmain, Philippa
    Askew, Sarah
    Singh, Kavita
    Chan, Kiong K.
    Ganesan, Raji
    Hirschowitz, Lynn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1201 - 1207
  • [43] The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas
    Salvador, Shannon
    Gilks, Blake
    Koebel, Martin
    Huntsman, David
    Rosen, Barry
    Miller, Dianne
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) : 58 - 64
  • [44] Bilateral high-grade serous carcinoma of the fallopian tube: Case report
    Popa, M.
    Poteca, A.
    Andrei, F.
    VIRCHOWS ARCHIV, 2016, 469 : S278 - S278
  • [45] Cytology of the fallopian tube: A screening model for high-grade serous carcinoma
    Dhanani, Maya
    Nassar, Aziza
    Charles, Melissa S.
    Tri Dinh
    CYTOJOURNAL, 2018, 15
  • [46] Discriminating Uterine Serous Carcinoma from High Grade Ovarian and Fallopian Tube Serous Carcinoma by Whole Genome Expression
    Ahmed, Q. F.
    Bandyopadyay, S.
    Alosh, B.
    AbdulFatah, E.
    Barak, S.
    Dyson, G.
    Bollig-Fischer, A.
    Ali-Fehmi, R.
    LABORATORY INVESTIGATION, 2014, 94 : 458A - 458A
  • [47] Discriminating Uterine Serous Carcinoma from High Grade Ovarian and Fallopian Tube Serous Carcinoma by Whole Genome Expression
    Ahmed, Q. F.
    Bandyopadyay, S.
    Alosh, B.
    AbdulFatah, E.
    Barak, S.
    Dyson, G.
    Bollig-Fischer, A.
    Ali-Fehmi, R.
    MODERN PATHOLOGY, 2014, 27 : 458A - 458A
  • [48] Serous Tubal Intraepithelial Carcinoma Localizes to the Tubal-peritoneal Junction: A Pivotal Clue to the Site of Origin of Extrauterine High-grade Serous Carcinoma (Ovarian Cancer)
    Seidman, Jeffrey D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2015, 34 (02) : 112 - 120
  • [49] High-grade serous ovarian cancer arises from fallopian tube in a mouse model
    Kim, Jaeyeon
    Coffey, Donna M.
    Creighton, Chad J.
    Yu, Zhifeng
    Hawkins, Shannon M.
    Matzuk, Martin M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (10) : 3921 - 3926
  • [50] Bilateral high-grade serous carcinoma of the fallopian tube with ovarian and uterine involvement - case report
    Popa, M.
    Enache, T.
    Olinca, M.
    Poteca, A.
    VIRCHOWS ARCHIV, 2021, 479 : S244 - S244